Trial Details
RECRUITINGBasic Information
| Clinical ID | c137 |
|---|---|
| Identifier | NCT06346288 |
| Trial Title | A Study to Assess the Concentrations of Risankizumab in the Breast Milk of Adult Lactating Women With Inflammatory Bowel Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Disease |
| Interventions | PROCEDURE: Breast Milk Sampling|DRUG: Risankizumab |
Participant Information
| Sponsor | AbbVie |
|---|---|
| City | Chapel Hill |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | FEMALE |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2024-04-24 |
|---|---|
| Primary Completion Date | 2025-08-25 |
| Completion Date | 2025-12-27 |